Guo‐Rui Dou
Impact in
- Ophthalmology top 2%
- Retinal Diseases and Treatments
- Hepatology top 5%
- Liver physiology and pathology
Papers in
-
- Retinal Diseases and Treatments 14
- Glaucoma and retinal disorders 7
-
- Liver physiology and pathology 4
- Journals
- PLoS ONE (4 papers)Experimental Eye Research (3 papers)Hepatology (3 papers)Neoplasia (2 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Guo‐Rui Dou
48 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 97
- Ophthalmology 304
- Hepatology 143
- Cancer Research 256
- Neurology 96
- Molecular Biology 716
Countries citing papers authored by Guo‐Rui Dou
This map shows the geographic impact of Guo‐Rui Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo‐Rui Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo‐Rui Dou more than expected).
Fields of papers citing papers by Guo‐Rui Dou
This network shows the impact of papers produced by Guo‐Rui Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo‐Rui Dou. The network helps show where Guo‐Rui Dou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guo‐Rui Dou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 14 | |
| 2 | 2024 | 9 | |
| 3 | 2023 | 19 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 0 | |
| 6 | 2021 | 1 | |
| 7 | 2021 | 22 | |
| 8 | 2020 | 4 | |
| 9 | 2019 | 50 | |
| 10 | 2018 | 12 | |
| 11 | 2018 | 46 | |
| 12 | 2018 | 24 | |
| 13 | 2017 | 1 | |
| 14 | 2014 | 23 | |
| 15 | 2011 | 62 | |
| 16 | 2011 | 36 | |
| 17 | Deficiency of B Crystallin Augments ER Stress-Induced Apoptosis by Accentuating Mitochondrial Dysfunction in RPE Cells | 2010 | 1 |
| 18 | 2009 | 32 | |
| 19 | 2009 | 33 | |
| 20 | 2008 | 47 |
About Guo‐Rui Dou
Guo‐Rui Dou is a scholar working on Ophthalmology, Hepatology, Neurology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 50 papers that have together received 1.3k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (14 papers), Angiogenesis and VEGF in Cancer (12 papers), Developmental Biology and Gene Regulation (8 papers), Glaucoma and retinal disorders (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Retinopathy of Prematurity Studies (6 papers), Corneal Surgery and Treatments (5 papers) and Liver physiology and pathology (4 papers). The work is most often cited by research in Ophthalmology (304 citations), Hepatology (143 citations), Cancer Research (256 citations), Neurology (96 citations) and Molecular Biology (716 citations). Guo‐Rui Dou has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Lin Wang, Hua Han, Zhiqiang Fang, Yusheng Wang, Juanli Duan, Yusheng Wang, Bai Ruan, Zhen‐Sheng Yue, David R. Hinton and Changmei Guo. Their work appears in journals such as PLoS ONE, Experimental Eye Research, Hepatology, Neoplasia and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.